1. Home
  2. OCFC vs AMPH Comparison

OCFC vs AMPH Comparison

Compare OCFC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanFirst Financial Corp.

OCFC

OceanFirst Financial Corp.

HOLD

Current Price

$18.20

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$17.30

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCFC
AMPH
Founded
1902
1996
Country
United States
United States
Employees
1007
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
OCFC
AMPH
Price
$18.20
$17.30
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$21.67
$28.38
AVG Volume (30 Days)
601.9K
466.6K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
4.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
$47.51
$6.90
Revenue Next Year
$21.97
$4.64
P/E Ratio
$16.71
$131.43
Revenue Growth
N/A
N/A
52 Week Low
$16.09
$17.03
52 Week High
$20.61
$31.26

Technical Indicators

Market Signals
Indicator
OCFC
AMPH
Relative Strength Index (RSI) 41.33 30.67
Support Level $17.29 $17.03
Resistance Level $18.62 $20.08
Average True Range (ATR) 0.45 0.80
MACD -0.11 -0.48
Stochastic Oscillator 19.87 2.19

Price Performance

Historical Comparison
OCFC
AMPH

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: